Cataracts. Age-related nuclear cataract
Conditions
Interventions
Intervention 1: Patients who received epinephrine without preservative with a concentration of 1.1000. Intervention 2: Intervention group: Patients who received epinephrine without preservative with a
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 210patients with cataract that refer to poostchi clinic
Exclusion criteria
Exclusion criteria: Patients with a history of eye surgery Patients with a history of eye trauma Patients with a history of diabetes mellitus and high eye pressure Patients with a history of exfoliation syndrome Patients with a history of corneal edema Patients with a history of macular problems Patients with any complications during the operation, including long phaco time, iris trauma and capsule rupture
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in macular thickness in the intervention groups. Timepoint: Before the intervention and three months later. Method of measurement: by specular device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Corneal endothelium cell density. Timepoint: Before operation and 3 month after operation. Method of measurement: Specular microscope.;The size of corneal endothelium cells. Timepoint: Before the operation and 3 months after the operation. Method of measurement: Specular microscope.;The shape of corneal endothelium cells. Timepoint: Before the operation and 3 months after the operation. Method of measurement: Specular microscope. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDoctor Shahram Bamdad
Shiraz University of Medical Sciences
Outcome results
None listed